Excessive Amount of Blood / Fluid Transfusion Clinical Trial
Official title:
Blood Transfusions May Impair Endothelium-dependent Vasodilatation in Isolated Left Mammary Arterial Artery Rings and Peripheral Artery Tonometry During Coronary Artery Bypass Surgery
The hemolytic product free-hemoglobin (fHb) reduces nitric oxide (NO) bioavailability. The present study aims to establish whether transfusions of stored allogenic blood or intraoperative autologous salvaged blood result in increased circulating fHb levels and NO consumption with effects on arterial NO-dependent blood flow measured in isolated left mammary artery rings and by peripheral artery tonometry in patients undergoing CABG surgery.
Introduction
Several studies have implicated red blood cell (RBC) transfusion as a risk factor for
increased morbidity as well as short- and long-term mortality after coronary artery bypass
graft surgery (CABG). Interestingly, this effect is most pronounced among patients
undergoing isolated CABG, suggesting that a harmful mechanism of RBC transfusion is not
generalizable to all types of surgical procedures but instead may be specific to those
patients.
The mechanisms by which blood transfusion may contribute to organ injury, dysfunction and
death remain uncertain. Besides the quantity of RBC transfusions, the quality of the product
has also been associated with differences in mortality and morbidity.
The use of intraoperative cell salvage and autologous blood transfusion has become an
important method of blood conservation. The main aim of autologous transfusion is to reduce
the need for allogeneic blood transfusion and its associated complications. However
hemolysis and high cell-free hemoglobin (fHb) contents are associated with cell washing
devices that collect anticoagulated shed or recovered blood, wash and separate the RBC by
centrifugation, and re-infuse the RBC.
fHb is a potent scavenger of nitric oxide (NO), which mediates endothelium-dependent
vasodilation, and may therefore be responsible for microvascular perfusion disturbances
(arterial spasm). Indeed endothelial dysfunction and persistent microvascular alterations
are associated with organ failure and death.
Increasing hemolysis and release of fHb were also documented as a function of time during
prolonged RBC storage. Transfusion of RBC stored for less than 14 days has been associated
with favourable outcomes when compared with transfusion of RBC stored for a prolonged time.
Changes in red cell structure and function during blood banking and storage have been
referred to as the red cell storage lesion.
The present study aimed to assess whether transfusion of stored allogeneic blood or
intraoperative autologous salvaged blood results in differently increased circulating fHb
levels and plasma NO consumption with effects on arterial NO-dependent blood flow in
patients undergoing CABG surgery.
Methods
Study design This single-centre, prospective observational cohort study was based on
consecutive patients undergoing elective isolated CABG with cardiopulmonary bypass (CPB) at
our institution between January 2014 and May 2014. Perioperative and postoperative data were
collected prospectively. The study protocol was approved by the Institution's Ethical
Committee/Institutional Review Board.
Surgery Anaesthesia was standardized and maintained with propofol, sufentanil and
vecuronium. Surgery was always performed through median sternotomy. LIMA was harvested as a
pedicle, anastomosed to the left anterior descending artery in all cases, and never used as
a free graft. CPB circuit included a Sorin phosphorylcholine-coated tubing set (Sorin Group
SpA, Milano, Italy), a Jostra roller pump (Jostra, Maquet Cardiopulmonary, Hirrlingen,
Germany), and a hollow fiber membrane coated oxygenator, which incorporated also a 40 μm
filter (Sorin Synthesis™, Sorin Group Spa, Milano, Italy). Heparin was given at a dose of
300 IU/kg to achieve a target activated clotting time of 480 s or above. The extracorporeal
circuit was primed with 1400 mL of Ringer's lactate solution and 5000 IU of heparin. A
non-pulsatile CPB flow was established at 2.4 L/min. Buckberg crystalloid cardioplegic
solution was used to maintain cardioplegia during aortic cross-clamping. Infusion of 4 mg/kg
of protamine was used to neutralize heparin after finishing the CPB. Residual blood was
sucked from the venous reservoir into the cell saver collection reservoir using a dual lumen
tube connected to a vacuum pump and subsequently transferred to the 125-ml centrifuge bowl
of the cell saver (Cell Saver 5; Haemonetics, Braintree, MA, USA). Cells were washed using
2000 ml bags NaCl 0.9% with 30.000 IU of heparin (Athena Pharma, Rome, Italy). The following
cell saver program was used for the cell saver: 5600 r.p.m., filling and washing rate of 250
ml/min, emptying rate 250 ml/min, wash volume 1000 ml. Concentrated blood cells were drained
into a patient labelled soft collection bag.
Transfusion protocol Transfusion of packed RBC was indicated at Hb levels < 7 g/l during
CPB. After the end of CPB an Hb level < 9 g/l indicated requirement of autologous salvaged
concentrated blood cells and/or packed RBC.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Unknown status |
NCT02149069 -
Blood Management Program in the Post - Operative Period.
|
N/A | |
| Not yet recruiting |
NCT01676740 -
Iron and Vitamin Adminstration Prior to Joint Replacement to Prevent Transfusion
|
N/A | |
| Recruiting |
NCT01390675 -
Anesthesia for Catheter Aortic Valve ImplantATIOn Registry
|